Vitrolife completes THE acquisition of Igenomix

Together, we create a global leader in reproductive health

It is with great pleasure that we can communicate Vitrolife AB has concluded the acquisition of Igenomix. The two separate companies will continue operating independently but, by combining Igenomix’s portfolio of reproductive genetic testing services with Vitrolife’s best-in-class IVF device portfolio, we will be able to better support clinics and patients across the fertility journey.